Press Releases about Gilead Sciences
![](https://www.marketbeat.com/logos/articles/med_20230518072749_vertex-pharmaceuticals-hits-record-high-on-strong.jpg)
![](https://mms.businesswire.com/media/20230516005951/en/1795631/5/GILEAD_KITE_Logo_Stack_RGB_012622.jpg)
![](https://media.prleap.com/image/92562/640/Kee_Cover.jpg)
![](https://mms.businesswire.com/media/20230516005214/en/1793877/5/IMG_3592.jpg)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://mms.businesswire.com/media/20230508005799/en/778437/5/GCP_Primarylarge_1.jpg)
![](https://mms.businesswire.com/media/20230504005222/en/778437/5/GCP_Primarylarge_1.jpg)
![](https://mms.businesswire.com/media/20230501005622/en/778437/5/GCP_Primarylarge_1.jpg)
Via Business Wire
![](https://mms.businesswire.com/media/20230427005279/en/778437/5/GCP_Primarylarge_1.jpg)
Via Business Wire
![](https://www.marketbeat.com/images/256x256-marketbeat-icon.png?v=2023)
6 Best Healthcare Stocks to Buy Right Now
April 25, 2023
Via MarketBeat
![](https://www.marketbeat.com/logos/articles/med_20230418120619_gamida-cell-stock-jumps-over-100-on-fda-approval.jpg)
![](https://mms.businesswire.com/media/20230413005889/en/778437/5/GCP_Primarylarge_1.jpg)
![](https://mms.businesswire.com/media/20230413005787/en/778437/5/GCP_Primarylarge_1.jpg)
![](https://mms.businesswire.com/media/20230320005679/en/778437/5/GCP_Primarylarge_1.jpg)
![](https://mms.businesswire.com/media/20230320005701/en/836069/5/NEW_KITE_COLOR_LOGO.jpg)
![](https://mms.businesswire.com/media/20230320005116/en/1741656/22/Nurix-Logo.jpg)
![](https://mms.businesswire.com/media/20230222005741/en/778437/5/GCP_Primarylarge_1.jpg)
![](https://mms.businesswire.com/media/20230222005588/en/836069/5/NEW_KITE_COLOR_LOGO.jpg)
Kite Completes Acquisition of Tmunity
February 22, 2023
Via Business Wire
![](https://mms.businesswire.com/media/20230217005363/en/778437/5/GCP_Primarylarge_1.jpg)
![](https://mms.businesswire.com/media/20230220005346/en/778437/5/GCP_Primarylarge_1.jpg)
![](https://mms.businesswire.com/media/20230216005947/en/778437/5/GCP_Primarylarge_1.jpg)
Via SBWire
Via SBWire
![](https://mms.businesswire.com/media/20230213005677/en/778437/5/GCP_Primarylarge_1.jpg)
Europe Liver Cancer Therapeutics Market to Reach at High CAGR of 8.95% by 2023-2030
February 09, 2023
Via SBWire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.